Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

186.32
Delayed Data
As of 11:08am ET
 +0.12 / +0.06%
Today’s Change
128.50
Today|||52-Week Range
314.88
+19.44%
Year-to-Date

Today’s Trading

Previous close186.20
Today’s open183.74
Day’s range183.09 - 187.87
Volume56,324
Average volume (3 months)347,308
Market cap$4.5B
Dividend yield--
Data as of 11:08am ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)-262.50%
Earnings growth (this year)+23.98%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.40%
P/E ratioNM
Price/Sales1,861.70
Price/Book17.27

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...+1.38+1.18%
AKRXAkorn Inc+0.17+0.44%
HZNPHorizon Pharma PLC-0.31-1.05%
NBIXNeurocrine Bioscienc...+0.41+0.85%
Data as of 11:26am ET, 09/04/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)-$2.77
Annual revenue (last year)$1.7M
Annual profit (last year)-$283.2M
Net profit margin-16,262.23%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts

Partner Offers